Search research articles
Contact Us
Filters
Showing results (111-120 of 163) with videos related to
Page
of 17
Sort By:
Clinical & Experimental Metastasis
|
November 8, 2021
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group
Ciro Franzese, Giulia Marvaso, Giulio Francolini, et al.
BJU International
|
June 19, 2024
Evaluation of margins during radical prostatectomy: confocal microscopy vs frozen section analysis
Gennaro Musi, Francesco A Mistretta, Mariia Ivanova, et al.
European Urology
|
January 21, 2025
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care
Vedang Murthy, Giulia Marvaso, Barbara A Jereczek-Fossa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 1, 2024
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis
Giulia Corrao, Giulia Marvaso, Federico Mastroleo, et al.
Tumori
|
July 15, 2017
Physicists' views on hadrontherapy: a survey of members of the Italian Association of Medical Physics (AIFM)
Tommaso Giandini, Chiara Tenconi, Mauro Carrara, et al.
World Journal of Urology
|
March 16, 2024
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE"
Giulia Marvaso, Giulia Corrao, Ilaria Repetti, et al.
Frontiers in Oncology
|
October 15, 2021
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300)
Stefania Russo, Rosalinda Ricotti, Silvia Molinelli, et al.
The British Journal of Radiology
|
November 1, 2018
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)
Barbara Alicja Jereczek-Fossa, Damaris Patricia Rojas, Dario Zerini, et al.
Cancers
|
April 13, 2023
Blood- and Imaging-Derived Biomarkers for Oncological Outcome Modelling in Oropharyngeal Cancer: Exploring the Low-Hanging Fruit
Stefania Volpe, Aurora Gaeta, Francesca Colombo, et al.
The British Journal of Radiology
|
May 12, 2018
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218
Giorgia Timon, Delia Ciardo, Alessia Bazani, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 163) with videos related to
Sort By:
Page
of 17
Clinical & Experimental Metastasis
|
November 8, 2021
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group
Ciro Franzese, Giulia Marvaso, Giulio Francolini, et al.
BJU International
|
June 19, 2024
Evaluation of margins during radical prostatectomy: confocal microscopy vs frozen section analysis
Gennaro Musi, Francesco A Mistretta, Mariia Ivanova, et al.
European Urology
|
January 21, 2025
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care
Vedang Murthy, Giulia Marvaso, Barbara A Jereczek-Fossa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 1, 2024
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis
Giulia Corrao, Giulia Marvaso, Federico Mastroleo, et al.
Tumori
|
July 15, 2017
Physicists' views on hadrontherapy: a survey of members of the Italian Association of Medical Physics (AIFM)
Tommaso Giandini, Chiara Tenconi, Mauro Carrara, et al.
World Journal of Urology
|
March 16, 2024
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE"
Giulia Marvaso, Giulia Corrao, Ilaria Repetti, et al.
Frontiers in Oncology
|
October 15, 2021
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300)
Stefania Russo, Rosalinda Ricotti, Silvia Molinelli, et al.
The British Journal of Radiology
|
November 1, 2018
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)
Barbara Alicja Jereczek-Fossa, Damaris Patricia Rojas, Dario Zerini, et al.
Cancers
|
April 13, 2023
Blood- and Imaging-Derived Biomarkers for Oncological Outcome Modelling in Oropharyngeal Cancer: Exploring the Low-Hanging Fruit
Stefania Volpe, Aurora Gaeta, Francesca Colombo, et al.
The British Journal of Radiology
|
May 12, 2018
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218
Giorgia Timon, Delia Ciardo, Alessia Bazani, et al.
Page
of 17